2399 — Biostar Microtech International Income Statement
0.000.00%
TechnologySpeculativeSmall CapValue Trap
- TWD2.46bn
- TWD1.29bn
- TWD2.77bn
- 34
- 69
- 31
- 38
Annual income statement for Biostar Microtech International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,443 | 3,040 | 1,673 | 2,105 | 2,775 |
Cost of Revenue | |||||
Gross Profit | 455 | 289 | 115 | 253 | 520 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,363 | 3,307 | 1,799 | 2,131 | 2,558 |
Operating Profit | 79.9 | -267 | -126 | -26.9 | 217 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 90.6 | -199 | -25.8 | 182 | 407 |
Provision for Income Taxes | |||||
Net Income After Taxes | 105 | -190 | -32.7 | 141 | 362 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 100 | -243 | 7.42 | 143 | 362 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 100 | -243 | 7.42 | 143 | 362 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.606 | -0.628 | -0.466 | 0.593 | 2.01 |
Dividends per Share |